These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3493068)

  • 1. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans.
    Hoon DS; Korn EL; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1740-4. PubMed ID: 3493068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies.
    Cochran AJ; Pihl E; Wen DR; Hoon DS; Korn EL
    J Natl Cancer Inst; 1987 Mar; 78(3):399-405. PubMed ID: 3469453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor cell activity in melanoma-draining lymph nodes.
    Hoon DS; Bowker RJ; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1529-33. PubMed ID: 2949828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative and functional study of breast cancer axillary lymph nodes and those draining other human malignant tumors.
    Di Girolamo V; Laguens RP; Coronato S; Salas M; Spinelli O; Portiansky E; Laguens G
    J Exp Clin Cancer Res; 2000 Jun; 19(2):155-9. PubMed ID: 10965811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracortical activity in the lymph nodes draining female breast carcinoma.
    Syrjänen KJ
    Neoplasma; 1979; 26(1):95-102. PubMed ID: 311901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes.
    O'Sullivan GC; Corbett AR; Shanahan F; Collins JK
    J Immunol; 1996 Nov; 157(10):4717-20. PubMed ID: 8906853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on lymphatic metastasis. I. Primary immunoregulatory role of regional lymph nodes in the establishment of lymphatic metastases.
    Yoshida K; Tachibana T
    J Natl Cancer Inst; 1985 Dec; 75(6):1049-58. PubMed ID: 2866267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
    Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
    J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression by melanoma cells as a factor in the generation of metastatic disease.
    Cochran AJ; Wen DR; Farzad Z; Stene MA; McBride W; Lana AM; Hoon DS; Morton DL
    Anticancer Res; 1989; 9(4):859-64. PubMed ID: 2683997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
    Saxon A; Portaro J
    Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response of regional lymph nodes in patients with lung cancer.
    Ogawa J; Inoue H; Koide S; Kawada S; Shohtsu A
    Tokai J Exp Clin Med; 1981 Jul; 6(3):259-66. PubMed ID: 6975508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased activity of lymph node cells in thermal injury.
    Kataranovski M; Kucuk J; Lilić D; Drasković-Pavlović B; Colić M; Pejnović N; Dujić A
    Reg Immunol; 1992; 4(4):197-203. PubMed ID: 1476871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive immunotherapy with tumor-specific T lymphocytes generated from cytokine gene-modified tumor-primed lymph node cells.
    Ohno K; Yoshizawa H; Tsukada H; Takeda T; Yamaguchi Y; Ichikawa K; Maruyama Y; Suzuki Y; Suzuki E; Arakawa M
    J Immunol; 1996 May; 156(10):3875-81. PubMed ID: 8621926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of melanoma on immune function in the regional lymph node basin.
    Negin B; Panka D; Wang W; Siddiqui M; Tawa N; Mullen J; Tahan S; Mandato L; Polivy A; Mier J; Atkins M
    Clin Cancer Res; 2008 Feb; 14(3):654-9. PubMed ID: 18245524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relevance of tumor draining lymph nodes in cancer.
    Heys SD; Eremin O
    Surg Gynecol Obstet; 1992 Jun; 174(6):533-40. PubMed ID: 1595033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental frontiers for clinical applications: novel approaches to understanding mechanisms of lymph node metastases in melanoma.
    Essner R
    Cancer Metastasis Rev; 2006 Jun; 25(2):257-67. PubMed ID: 16770538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.